A5013026443- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Pediatric Hepatobiliary Diseases and Treatments
- Radiopharmaceutical Chemistry and Applications
- Organ Transplantation Techniques and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Transplantation: Methods and Outcomes
- Gallbladder and Bile Duct Disorders
- Global Health Workforce Issues
- Diversity and Career in Medicine
- Renal cell carcinoma treatment
- MRI in cancer diagnosis
- Kidney Stones and Urolithiasis Treatments
- Uterine Myomas and Treatments
- Advanced Radiotherapy Techniques
- Central Venous Catheters and Hemodialysis
- Medical Imaging and Pathology Studies
- Urinary Tract Infections Management
- Nuclear Materials and Properties
- Prostate Cancer Diagnosis and Treatment
- Urinary Bladder and Prostate Research
- Renal Transplantation Outcomes and Treatments
- Cardiac Arrhythmias and Treatments
- Intestinal Malrotation and Obstruction Disorders
University of Rochester Medical Center
2024
MedStar Georgetown University Hospital
2017-2021
Georgetown University
2014-2021
Icahn School of Medicine at Mount Sinai
2019
Ospedale Policlinico San Martino
2013
Istituti di Ricovero e Cura a Carattere Scientifico
2013
Known risk factors for hepatocellular adenoma (HCA) bleeding are size >5 cm, growth rate, visible vascularity, exophytic lesions, β-catenin and Sonic Hedgehog activated HCAs. Most studies based on European cohorts. The objective of this study is to identify additional HCA in a US cohort.Retrospective chart review was performed patients diagnosed with magnetic resonance imaging (n = 184) at an academic tertiary institution. Clinical, pathological, data were collected. Primary outcomes...
Hepatocellular carcinoma is the most common primary hepatic malignancy. For patients not amenable to surgical treatment, transarterial chemoembolization a viable therapeutic alternative. Extrahepatic collateral arterial supply tumor may occur in variety of scenarios and timely detection this phenomenon fundamental importance achieve optimal outcomes response treatment. This report presents case hepatocellular that was supplied mainly by parasitized right phrenic artery only successfully...
Background. Standard maintenance immunosuppression after intestinal transplantation (ITx) currently consists of tacrolimus-based regimens. We previous reported that adding sirolimus significantly reduces rejection rates and graft loss. now present our decade-long experience with in ITx. Patients. 160 patients (87M 73F, n=80 adults (median age 42 y [18-66], children 1.6 [6 mo-17.5 y] undergoing primary ITx (87 isolated small intestine, 44 liver-intestine, 24 multivisceral 5 modified MV)...
Aim There is no consensus on the optimal preservation solution in DCD liver transplantation (LTx), especially regarding risk of ischemic-type biliary lesions (ITBL). Both UW and HTK solutions have been successfully used. We reviewed our experience with both LTx. Methods performed 35 adult primary LTx between 1/2008-10/2013. was used 24(69%) grafts (group A) 11(31%, group B), depending procuring OPO protocol. Donor age, BMI, ethnicity, warm ischemia time macrosteatosis (gr. A biopsies n=14,...